Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237510 · ClinicalTrials.gov registry record · NA
Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
A NA study of Antidepressant Induced Excessive Sweating, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00237510 is a NA study of Antidepressant Induced Excessive Sweating that has completed, run by Thomas Jefferson University. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00237510, a NA study of Antidepressant Induced Excessive Sweating, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have minimal adverse effects.
Conditions Studied
Interventions
- DRUG terazosin
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Department of Psychiatry and Human Behavior - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00237510
The ClinicalTrials.gov registry entry for NCT00237510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Antidepressant Induced Excessive Sweating appearing as the primary indexed condition, and to 1 intervention - of which terazosin is the first listed.
NCT00237510 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00237510 about?
NCT00237510 is a clinical study titled "Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating". This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have minimal adverse effects.
What is the current status of trial NCT00237510?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2005-05. Estimated completion is 2007-05.
What conditions does trial NCT00237510 study?
This clinical trial studies the following conditions: Antidepressant Induced Excessive Sweating.
What interventions are being tested in trial NCT00237510?
The interventions under investigation include: terazosin (DRUG).
Who is sponsoring clinical trial NCT00237510?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00237510 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.